日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Neoadjuvant palbociclib and endocrine therapy versus chemotherapy in ER + /HER2- breast cancer: a randomized phase II trial

新辅助帕博西尼联合内分泌治疗与化疗治疗ER+/HER2-乳腺癌:一项随机II期试验

Matikas, Alexios; Tzoras, Evangelos; Sarafidis, Michail; Sifakis, Emmanouil G; Bjöhle, Judith; Barnekow, Elin; Margolin, Sara; Isaksson-Friman, Erika; Kessler, Luisa Edman; Zouzos, Athanasios; Johansson, Hemming; Hellström, Mats; Agartz, Susanne; Grybäck, Per; Salgkamis, Dimitrios; Zerdes, Ioannis; Wang, Kang; Hartman, Johan; Acs, Balazs; Sun, Wenwen; Boyaci, Ceren; Villacampa, Guillermo; Pascual, Tomas; Gavila, Joaquin; Prat, Aleix; Perou, Charles; Brandberg, Yvonne; Bergh, Jonas; Hatschek, Thomas; Foukakis, Theodoros

Precision oncology in a dish: patient-derived glioma organoids to guide novel therapeutic strategies

精准肿瘤学在体外:利用患者来源的胶质瘤类器官指导新型治疗策略

Monago-Sánchez, Alvaro; Mateos-Madrigal, Laura; Carrión-Navarro, Josefa; Hernández-Martínez, Ana; Martínez-Riveiro, Carlos; Castelló-Pons, María; Pacheco-Fuenmayor, María Victoria; Gutiérrez-González, Raquel; Lomillos-Prieto, Noemí; Prat-Acín, Ricardo; Mathieu, Santiago Gil-Robles; Aracil-González, Cristina; Pérez-Núñez, Angel; Pérez-Rodríguez, Francisco; Sánchez-Gómez, Pilar; Martín-Jouve, Beatriz; Sánchez-López, Antonio J; García-Romero, Noemi; Ayuso-Sacido, Ángel

MYCT1-IFITM2/3 interaction links endothelial endolysosomal trafficking to white adipose tissue expansion.

MYCT1-IFITM2/3 相互作用将内皮细胞内溶酶体运输与白色脂肪组织扩张联系起来。

Wetterwald Laureline, Köck Anna, Wyss Tania, Arroz-Madeira Silvia, Prat-Luri Borja, Jaquet Muriel, Petit Benoît, Vozenin Marie-Catherine, Ylä-Herttuala Seppo, Dutoit Valérie, Migliorini Denis, Schaeuble Karin, Brisken Cathrin, Delorenzi Mauro, Sabine Amélie, Petrova Tatiana V

Associations of the HER2DX Genomic Test with Biological and Pathologic Features in HER2-Positive Breast Cancer

HER2DX基因组检测与HER2阳性乳腺癌生物学和病理特征的关联

Sanfeliu, Esther; Martínez-Romero, Anabel; Marín-Aguilera, Mercedes; Cobo, Sandra; González-Farré, Blanca; Hernandez-Illan, Eva; Jares, Pedro; Puig-Butillé, Joan Antón; Muñoz, Montserrat; Gómez-Bravo, Raquel; Tapia, Marta; Tebar, Cristina; Saura, Cristina; Escrivà-de-Romaní, Santiago; Soberino, Jesús; Cortés, Javier; Morales, Serafin; Amillano, Kepa; Paré, Laia; Villagrasa, Patricia; Buckingham, Wesley; Pardo, Francisco; Parker, Joel S; Brasó-Maristany, Fara; Ciruelos, Eva; Sánchez-Bayona, Rodrigo; Martinez-Sáez, Olga; Cejalvo, Juan Miguel; Prat, Aleix

Pembrolizumab and Paclitaxel in Patients with HR+/HER2- Breast Cancer with HER2-Enriched or Basal-like Subtypes

帕博利珠单抗联合紫杉醇治疗 HR+/HER2- 乳腺癌患者,包括 HER2 富集型或基底样亚型

Conte, Benedetta; Brasó-Maristany, Fara; Pascual, Tomás; Hernando, Cristina; Vázquez, Silvia; Blanch, Salvador; Oliveira, Mafalda; Virizuela, Juan Antonio; Muñoz, Montserrat; Seguí, Elia; Rodriguez-Hernandez, Adela; Vidal Losada, Maria Jesus; Galván, Patricia; Castillo, Oleguer; Blasco, Paula; Alva, Manuel; Chic, Nuria; Sanfeliu, Esther; Cano-Crespo, Sara; Salvador, Fernando; Villacampa, Guillermo; Villanueva, Lorea; Ferrero-Cafiero, Juan Manuel; Vivancos, Ana; Prat, Aleix; Ciruelos, Eva

Erratum to "Identifying predictors of treatment response and molecular changes induced by neoadjuvant chemotherapy and endocrine therapy in hormone receptor-positive/HER2-negative breast cancer: the NEOENDO translational study": [ESMO Open 9 (2024) 103989]

更正“识别激素受体阳性/HER2阴性乳腺癌新辅助化疗和内分泌治疗引起的治疗反应和分子变化的预测因子:NEOENDO转化研究”:[ESMO Open 9 (2024) 103989]

Schettini, F; Brasó-Maristany, F; Pascual, T; Lorman-Carbó, N; Nucera, S; Bergamino, M; Galván, P; Conte, B; Seguí, E; García Fructuoso, I; Gómez Bravo, R; Rodríguez, A B; Martínez-Sáez, O; Chic, N; Vidal, M; Adamo, B; González-Farre, B; Sanfeliu, E; Cebrecos, I; Mensión, E; Oses, G; Locci, M; Mollà, M; Ganau, S; Jares, P; Vidal-Sicart, S; Muñoz, M; Prat, A

TRPML1 suppresses pulmonary fibrosis by limiting collagen and elastin deposition.

TRPML1 通过限制胶原蛋白和弹性蛋白的沉积来抑制肺纤维化。

Weiden Eva-Maria, Serianz Zala, Klingl Yvonne, Jörs Simone, Jaślan Dawid, Keller Marco, Castro Sandra Prat, Mkhitaryan Mane, Jeridi Aicha, Briukhovetska Daria, Spix Barbara, Scotto Rosato Anna, Agami Ahmed, Schiller Herbert B, Rajan Suhasini, Schredelseker Johann, Fois Giorgio, Frick Manfred, Kobold Sebastian, Klein Margarethe, Geisler Fabian, Garcia-Fortanet Jorge, Murphy Leon O, Bracher Franz, Wahl-Schott Christian, Gudermann Thomas, Dietrich Alexander, Biel Martin, Yildirim Ali Önder, Grimm Christian

Quantitative HER2 tissue and plasma profiling predicts the activity of trastuzumab deruxtecan for breast cancer.

定量 HER2 组织和血浆分析可预测曲妥珠单抗 deruxtecan 对乳腺癌的活性。

Tarantino Paolo, Kim Se-Eun, Hughes Melissa E, Kusmick Ross J, Smith Kalie, Brasó-Maristany Fara, Nyein Chan Nay Nwe, Paré Brunet Laia, Alder Laura, Garcia-Cortes Diana, Gomez Tejeda Zanudo Jorge, Pereslete Alyssa M, Noteware Laura, Moore Heather, Van Swearingen Amanda E D, Li Tianyu, Gupta Hersh, D'Amico Olivia, Martini Alba, Morganti Stefania, Spindel Jennifer, Cook Charmaine, McLaughlin Christine, Dvir Kathrin, Garrido-Castro Ana C, Sammons Sarah, Files Janet, Sendrick Kerry, Buck Simone, Dillon Deborah, Jeselsohn Rinath, Li Yvonne Y, Cherniack Andrew D, LoRusso Patricia, Lustberg Maryam, Vega-León Rosario, Pardo Francisco, Davis Justin, Mueller Claudius, Corgiat Brian, Curigliano Giuseppe, Anders Carey K, Petricoin Emanuel F, Rimm David L, Prat Aleix, Tayob Nabihah, Lin Nancy U, Tolaney Sara M

Dynamic biomarkers in hormone receptor-positive/HER2-negative breast cancer trials: a new hope for precision oncology

激素受体阳性/HER2阴性乳腺癌试验中的动态生物标志物:精准肿瘤学的新希望

Di Grazia, Giuseppe; Sánchez-Bayona, Rodrigo; Casals-Pascual, Climent; Pascual, Tomás; Generali, Daniele; Gennari, Alessandra; Vigneri, Paolo; Harbeck, Nadia; Cortés, Javier; Prat, Aleix; Schettini, Francesco

Validation of the HER2DX genomic test in first-line advanced HER2-positive breast cancer treated with trastuzumab, pertuzumab, and taxane

验证 HER2DX 基因组检测在接受曲妥珠单抗、帕妥珠单抗和紫杉烷一线治疗的 HER2 阳性晚期乳腺癌患者中的应用价值

Kubeczko, Marcin; Cobo, Sandra; Sanchez-Bayona, Rodrigo; Pyciński, Bartłomiej; Soberino, Jesús; Chmielik, Ewa; Sanfeliu, Esther; Rey, Maria; Pardo, Francisco; Aguirre, Angela; Castillo, Oleguer; Lesniak, Aleksandra; Oczko-Wojciechowska, Malgorzata; Carcelero, Esther; Adamo, Barbara; Vidal, Maria; Bergamino, Milana; Maues, Julia; Villacampa, Guillermo; Paré, Laia; Villagrasa, Patricia; Ciruelos, Eva; Prat, Aleix; Jarzab, Michal; Brasó-Maristany, Fara